To the best of our knowledge, this is the first effort to unveil a novel autoimmunity to IFN-α epitopes and its possible clinical significance in a well-characterized cohort of people with different forms of AD and different profiles of disease progression. This evidence concerns the gene IFNA2 and Alzheimer disease.